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The globally rising incidences of multidrug-resistant (MDR) Pseudomonas aeruginosa
(Psae) in humans and live-stock animals has prompted the World Health Organization
to rate MDR Psae as serious threat for human health. Only little is known, however,
regarding factors facilitating gastrointestinal Psae-acquisition by the vertebrate host
and subsequently induced inflammatory sequelae. In the present study, we addressed
whether subacute ileitis predisposed mice harboring a human gut microbiota for
intestinal MDR Psae carriage and whether inflammatory responses might be induced
following peroral challenge with the opportunistic pathogen. To accomplish this,
secondary abiotic mice were associated with a human gut microbiota by fecal
microbiota transplantation. Ten days later (i.e., on day 0), subacute ileitis was induced
in human microbiota associated (hma) mice by peroral low-dose Toxoplasma gondii
infection. On day 5 post-infection, mice were perorally challenged with 109 colony
forming units of a clinical MDR Psae isolate by gavage and the fecal bacterial
loads surveyed thereafter. Four days post-peroral challenge, only approximately
one third of mice with a human gut microbiota and subacute ileitis harbored the
opportunistic pathogen in the intestinal tract. Notably, the gut microbiota composition
was virtually unaffected by the Psae-carriage status during subacute ileitis of hma
mice. The Psae challenge resulted, however, in more pronounced intestinal epithelial
apoptotic cell and T lymphocyte responses upon ileitis induction that were not
restricted to the ileum, but also affected the large intestines. Higher Psae-induced
abundances of T cells could additionally be observed in extra-intestinal compartments
including liver, kidney, lung, and heart of hma mice with subacute ileitis. Furthermore,
higher apoptotic cell numbers, but lower anti-inflammatory IL-10 concentrations
were assessed in the liver of Psae as compared to mock treated mice with
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ileitis. Remarkably, Psae-challenge was accompanied by even more pronounced
systemic secretion of pro-inflammatory cytokines such as TNF and IL-6 at day 9 post
ileitis induction. In conclusion, whereas in one third of hma mice with subacute ileitis
Psae could be isolated from the intestines upon peroral challenge, the opportunistic
pathogen was responsible for inflammatory sequelae in intestinal, extra-intestinal, and
even systemic compartments and thus worsened subacute ileitis outcome irrespective
of the Psae-carrier status.
Keywords: multi-drug resistant Pseudomonas aeruginosa, subacute ileitis, susceptibility to infection, host-
pathogen-interaction, human microbiota associated mice
INTRODUCTION
Pseudomonas aeruginosa (Psae) constitute Gram-negative,
non-fermenting bacteria that grow under strictly aerobic
conditions and can be preferably found in moist environments
(1). Bacterial motility and adhesive properties are provided by
a single flagellum and several cell surface pili. A plethora of
additional virulence factors such as alginate secretion, biofilm
formation, quorum-sensing, an elaborate secretion system as
well as intrinsic expression of antibiotic resistance genes facilitate
adaptation to the respective environment as well as immune
escape and establishment in the ecosystem of the vertebrate
host (1, 2). Psae are considered opportunistic pathogens,
but may cause urinary tract infections, ventilator-associated
pneumonia, surgical and burn wound as well as bloodstream
infections, particularly in hospitalized individuals with immuno-
suppressive comorbidities such as neutropenia that are associated
with mortality rates of>30% (3). Furthermore, patients suffering
from chronic respiratory morbidities including chronic
obstructive lung disease, bronchiectasis, or cystic fibrosis are
prone to chronic Psae infection, further exacerbating the
underlying disease (3). Particularly the emergence of multidrug-
resistant (MDR) Psae strains due to bacterial expression of
resistance genes such as β-lactamases, 16S rRNA methylases,
and carbapenemases in recent years leading to severe infections
with high mortality rates due to very limited treatment options
has prompted the World Health Organization (WHO) in 2017
to rate MDR Gram-negative bacteria including Psae as serious
global threats to human health, further emphasizing the need for
novel (antibiotics-independent) treatment strategies (4).
In the healthcare setting, contaminated devices including
respiratory equipment, but also water bottles and sinks are
typical external sources for Psae acquisition (5, 6). Whereas,
Psae is not considered as part of the commensal gut microbiota,
a previous report revealed that rectal opportunistic bacterial
Abbreviations:CFU, colony forming units; FMT, fecal microbiota transplantation;
GIT, gastrointestinal tract; H&E, hematoxylin and eosin; hma, human microbiota
associated; HPF, high power field; ICU, intensive care unit; MDR, multidrug-
resistant; MLN, mesenteric lymph nodes; NO, nitric oxide; PBS, phosphate
buffered saline; Psae, Pseudomonas aeruginosa; SPF, specific pathogen free; TLR,
Toll-like receptor; Treg, regulatory T cells; WHO, World Health Organization;
WT, wildtype
carriage was a predictor for Psae-associated infections in patients
admitted to an intensive care unit (ICU) lateron (7). Thus,
the human gastrointestinal tract (GIT) should be taken into
consideration as a potential internal Psae reservoir. Particularly
in cases, when the integrity of the complex gut microbiota
is disturbed following antimicrobial therapy, for instance, the
compromised colonization resistance [physiologically preventing
the host from establishment of (opportunistic) pathogens (8,
9)] may facilitate stable Psae colonization within the human
gastrointestinal ecosystem (10, 11). In an earlier report, Psae
could be isolated from fecal samples of healthy volunteers
up to 1 week following ingestion with decreasing loads over
time, whereas the challenged individuals did not exhibit any
clinical complications (12). Valid information regarding the
immunopathological potential of intestinal Psae colonization in
the vertebrate host is scarce, however.
Recently, our group provided evidence for the first time
that intestinal carriage of a clinical MDR Psae isolate resulted
in pronounced pro-inflammatory sequelae in intestinal as well
as systemic compartments of healthy wildtype (WT) mice (13,
14). Furthermore, pre-existing inflammatory conditions in the
gut facilitated stable intestinal Psae colonization in mice (15,
16), which subsequently aggravated chronic colitis (16). In the
present study we addressed whether peroral challenge of mice
suffering from more acute intestinal inflammatory conditions
in a different anatomic compartment within the GIT (namely,
subacute ileitis) worsened the outcome of the underlying
disease. Since the host specific gut microbiota is known to
be essentially involved in the onset, progress and outcome
of distinct immunopathological conditions including intestinal
inflammation (8, 9, 17, 18), we aimed at mimicking human
gut microbiota conditions in the applied experimental model.
We therefore generated mice that were harboring a human gut
microbiota following human fecal microbiota transplantation
(FMT) and induced subacute ileitis by peroral low-dose
Toxoplasma gondii infection as described by us recently (19, 20).
We here show that approximately one third of humanmicrobiota
associated (hma) mice with subacute ileitis harbored Psae in their
intestines upon oral challenge. The opportunistic pathogen was,
however, responsible for pro-inflammatory immune responses
in intestinal, extra-intestinal and even systemic compartments
and, thus, worsened subacute ileitis outcome irrespective of
the Psae-carrier status.
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MATERIALS AND METHODS
Ethics Statement
Mouse experiments were performed in accordance of the
European Guidelines for animal welfare (2010/63/EU) and had
been approved by the commission for animal experiments
headed by the “Landesamt für Gesundheit und Soziales”
(LaGeSo, Berlin; registration numbers G0097/12 and G0039/15)
before. Clinical conditions including body weight loss were
assessed daily to assure animal welfare. Mice displaying over 20%
weight loss were subjected to cervical dislocation in accordance
with the guidelines of the local legal authorities.
Generation of Mice With a Human Gut
Microbiota by Fecal Microbiota
Transplantation
Female C57BL/6j mice weremaintained under specific pathogen-
free (SPF) conditions in the Forschungseinrichtungen für
Experimentelle Medizin (FEM, Charité - University Medicine,
Berlin, Germany). Microbiota depleted (i.e., secondary abiotic)
mice were obtained following broad-spectrum antibiotic
treatment as described earlier (8, 17). In brief, 8-week-old mice
were treated with a quintuple antibiotic cocktail containing
ampicillin plus sulbactam (1 g/L; Ratiopharm, Germany),
vancomycin (500 mg/L; Cell Pharm, Germany), ciprofloxacin
(200 mg/L; Bayer Vital, Germany), imipenem (250 mg/L; MSD,
Germany), and metronidazole (1 g/L; Fresenius, Germany) via
the drinking water for 8 weeks (ad libitum). Both, culture and
16S rRNA based molecular methods revealed virtual absence
of bacteria in fecal samples as described previously (8, 18).
Three days before human FMT the antibiotic cocktail was
replaced by sterile tap water (ad libitum) to assure antibiotic
washout (Supplemental Figure S1). Fresh fecal samples free of
enteropathogenic bacteria, viruses, and parasites were collected
from five individual healthy human volunteers, dissolved in
sterile phosphate buffered saline (PBS; Gibco, Life Technologies,
United Kingdom) and stored at −80◦C as stated elsewhere
(8). Individual fecal aliquots were thawed immediately before
FMT and pooled. In turn, secondary abiotic mice were perorally
challenged with the human fecal donor suspension on three
consecutive days by gavage (8). Notably, the inter-experimental
variations in bacterial loads of the donor suspensions were < 0.5
logarithmic orders of magnitude (Supplementary Figure S2).
In order to guarantee proper establishment of the complex
human gut microbiota within the murine host, mice were kept
for 10 days before subacute ileitis induction. Immediately before
peroral T. gondii infection (day 0) individual fecal samples were
collected for quantitative molecular analyses of main intestinal
bacterial communities as described elsewhere (8, 17, 21).
Molecular Analysis of the Human Fecal
Donor Suspensions and the Intestinal
Microbiota
Fresh ileal and colonic luminal samples were immediately
snap-frozen in liquid nitrogen and stored at −80◦C until
further processing. DNA was extracted from fecal samples
as reported earlier (17). In brief, for quantification of DNA
the Quant-iT PicoGreen reagent (Invitrogen, UK) was applied
and DNA in samples adjusted to 1 ng per µL. Then,
total eubacterial loads as well as the main bacterial groups
within the human gut microbiota such as enterobacteria,
enterococci, lactobacilli, bifidobacteria, Bacteroides/Prevotella
species, Clostridium coccoides group, and Clostridium leptum
group were surveyed by quantitative real-time polymerase chain
reaction using genera-, group- or species-specific 16S rRNA gene
primers (Tib MolBiol, Germany) as stated elsewhere (21, 22) and
numbers of 16S rRNA gene copies per ng DNA of each sample
assessed.
Induction of Subacute Ileitis
On day 0, mice were infected perorally with one cyst of T. gondii
ME49 strain (in a volume of 0.3mL brain suspension) by gavage
in order to induce subacute ileitis (Supplemental Figure S1), as
reported recently (19).
MDR P. aeruginosa Infection and
Quantitative Assessment of Fecal Bacterial
Loads
The MDR Psae isolate was initially isolated from respiratory
material of a patient with nosocomial pneumonia and kindly
provided by Prof. Dr. Bastian Opitz (Charité–University
Medicine, Berlin, Germany). Notably, the bacterial strain
displayed antimicrobial sensitivity to fosfomycin and colistin
only (15). Prior infection, the Psae strain was grown on cetrimide
agar (Oxoid) for 48 h in an aerobic atmosphere at 37◦C.
On day 5 post ileitis induction, mice were perorally challenged
with 109 colony forming units (CFU) of the MDR Psae strain
by gavage in a total volume of 0.3mL PBS as reported earlier
(Supplemental Figure S1) (15).
For quantitative assessment of Psae colonization densities in
the intestinal tract post-challenge, fecal and intestinal luminal
samples were homogenized in sterile PBS. Serial dilutions were
then streaked onto Columbia agar supplemented with 5%
sheep blood (Oxoid, Germany) and onto cetrimide agar and
incubated in an aerobic atmosphere at 37◦C for 48 h as described
previously (15). Difference of the sample weights before and after
asservation revealed respective fecal weights. The detection limit
of cultivable bacteria was∼100 CFU per g.
Cultural Survey of Bacterial Translocation
In order to survey viable bacteria translocating from the intestinal
tract to extra-intestinal and systemic compartments, ex vivo
biopsies derived from mesenteric lymph nodes (MLN), spleen,
liver, kidney and lung were homogenized in sterile PBS and
analyzed in serial dilutions on respective solid media as described
earlier (17, 23, 24). Cardiac blood was incubated in thioglycolate
enrichment broths (BD Bioscience, Germany) for 1 week at
37◦C and streaked onto solid media thereafter (15). Bacteria
were grown at 37◦C for at least two and t3 days under aerobic,
microaerobic and anaerobic conditions.
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Clinical Conditions
Macroscopic and / or microscopic occurrence of blood in murine
fecal pellets was surveyed in individual mice on a daily basis
by the Guajac method (Haemoccult; Beckman Coulter/ PCD,
Germany) as stated elsewhere (25).
Sampling Procedures
96 h following Psae challenge (i.e., day 9 post ileitis induction),
mice were sacrificed by isoflurane treatment [Abbott, Germany
(Figure S1)]. Cardiac blood (for serum) and tissue samples
from spleen, liver, lung, heart, MLN, ileum, and colon were
removed under sterile conditions. Respective ex vivo biopsies
were collected from each mouse in parallel for microbiological,
immunological and immunohistochemical analyses.
Histopathology
Ex vivo biopsies taken from the terminal ileum were fixed in
5% formalin and embedded in paraffin. Sections (5µm) were
stained with hematoxylin and eosin (H&E) and subjected to a
standardized histopathological scoring system ranging from 0 to
6 as described in more detail earlier (17).
Immunohistochemistry
Five µm thin paraffin sections of ileal and colonic ex vivo
biopsies were used for in situ immunohistochemical analysis
as reported previously (21, 26–28). In brief, to assess apoptotic
cells, proliferating cells, T lymphocytes and regulatory T
cells (Treg), primary antibodies against cleaved caspase-
3 (Asp175, #9661, Cell Signaling, Leiden, Netherlands;
1:200), Ki67 (clone 16A8, #652401, BioLegend/Biozol,
Eching, Germany; 1:200), CD3 (#IR50361-2, Dako, Santa
Clara, CA, USA; 1:5) and FOXP3 (clone FJK-165, #14-5773,
eBioscience, Frankfurt, Germany; 1:100), respectively, were
used. An independent blinded investigator determined
the average numbers of positively stained cells in at
least six high power fields (HPF, 0.287 mm2; 400 x
magnification).
Cytokine Detection
Ex vivo biopsies (∼1 cm2) derived from colon and ileum
(both cut longitudinally and washed in PBS), as well as
from liver (∼1 cm2), kidney (cut longitudinally, one half),
lung (one organ), spleen (one half), and MLN (3 single
lymph nodes) were transferred to 24-flat-bottom well culture
plates (Falcon, Germany) containing 500µL serum-free RPMI
1640 medium (Gibco, life technologies) supplemented with
penicillin (100 U/mL, Biochrom, Germany) and streptomycin
(100µg/mL; Biochrom). After 18 h at 37◦C, IFN-γ, TNF,
MCP-1, IL-6, and IL-10 concentrations were measured in
culture supernatants and serum by the Mouse Inflammation
Cytometric Bead Assay (CBA; BD Bioscience) applying a BD
FACSCanto II flow cytometer (BD Bioscience). Nitric oxide
(NO) concentrations were determined by the Griess reaction as
described earlier (17).
Statistical Analysis
Medians and levels of significance were determined by the one-
way ANOVA test followed by Tukey post-correction test for
multiple comparisons. Two-sided probability (p) values ≤0.05
were considered significant. Experiments were reproduced three
times.
FIGURE 1 | Intestinal MDR Pseudomoas aeruginosa loads following peroral challenge of mice with a human gut microbiota suffering from subacute ileitis. Secondary
abiotic mice were generated by broad-spectrum antibiotic treatment and associated with a complex human gut microbiota by fecal microbiota transplantation. Ten
days thereafter, subacute ileitis was induced by peroral infection of human microbiota associated mice with one cyst of T. gondii ME49 strain (day 0). On day 5 post
ileitis induction (p.i.), mice were perorally challenged with MDR P. aeruginosa (Psae) and (A) the fecal Psae loads were followed up for further 96 h by culture. (B) In
addition, Psae counts were assessed in the small as well as large intestinal lumen 96 h post Psae challenge. Box plots represent the 75th and 25th percentiles of the
median (black bar inside the boxes). Total range and significance levels determined by one-way ANOVA test followed by Tukey post-correction test for multiple
comparisons are shown. Numbers of mice harboring Psae in the respective intestinal compartment out of the total numbers of analyzed animals are given in
parentheses. Data were pooled from four independent experiments.
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RESULTS
Colonization Properties of MDR P.
aeruginosa in the Intestinal Tract of Mice
With a Human Gut Microbiota Suffering
From Subacute Ileitis
In the present study we raised the question whether subacute
ileitis predisposed mice with a human gut microbiota for
intestinal MDR Psae carriage and whether intestinal, extra-
intestinal or even systemic inflammatory sequelae might be
induced following peroral Psae challenge. To address this,
secondary abiotic mice were associated with a complex human
gut microbiota by FMT on three consecutive days. Ten days later
(i.e., on day 0), subacute ileitis was induced by peroral low-dose
T. gondii infection of hma mice. On day 5 post ileitis induction,
mice were perorally challenged with 109 CFU of a clinical
MDR P. aeruginosa isolate by gavage and the fecal opportunistic
pathogenic loads surveyed thereafter (Supplemental Figure S1).
As early as 24 h following peroral challenge, fecal Psae could be
cultured from all mice with median loads of ∼105 CFU per g
(Figure 1A). At later time points (48, 72, and 96 h, respectively),
however, both fecal Psae positivity rates (88.9, 66.7, and 33.3%,
respectively) as well as median Psae loads (p < 0.001; Figure 1A)
were lower, whereas at the end of the experiment, Psae could
be isolated from the ileal and colonic lumen in 22.2% and
33.3% of cases, respectively, (Figure 1B). Hence, only one third
of mice with a human gut microbiota and subacute ileitis
harbored MDR Psae in their intestinal tract 4 days post peroral
challenge.
Gut Microbiota Changes in Mice With a
Human Gut Microbiota and Subacute Ileitis
Following MDR P. aeruginosa Challenge
We next addressed whether MDR Psae challenge following
subacute ileitis induction resulted in intestinal microbiota
changes in mice with a human gut microbiota (Figures 2A–H).
Quantitative culture-independent analysis revealed that until day
9 following ileitis induction mock treated hma mice displayed
increased ileal loads of enterobacteria and enterococci (p <
0.05; Figures 2B,C), whereas both ileal Clostridium coccoides
FIGURE 2 | Ileal microbiota changes following MDR P. aeruginosa challenge of mice with a human gut microbiota suffering from subacute ileitis. Subacute ileitis was
induced in mice harboring a human gut microbiota by peroral T. gondii infection on day (d) 0. At day 5 post ileitis induction mice were either perorally challenged with
MDR P. aeruginosa (+Psae, dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as control animals
(Naive). (A–H) The microbiota composition of the ileal lumen was determined 96 h later by quantitative Real-Time PCR amplifying bacterial 16S rRNA variable regions
of the main intestinal bacterial groups (expressed as 16S rRNA gene numbers per ng DNA) including the total eubacterial load. Box plots represent the 75th and 25th
percentiles of the median (black bar inside the boxes). Total range and significance levels determined by one-way ANOVA test followed by Tukey post-correction test
for multiple comparisons are shown. Numbers of mice harboring respective bacterial groups in the ileal lumen out of the total numbers of analyzed animals are given in
parentheses. Data were pooled from four independent experiments.
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and Clostridium leptum group gene numbers were lower as
compared to naive hma mice without ileitis (p < 0.001 and
p < 0.005, respectively; Figures 2G,H). At day 9 post ileitis
induction, lower Bacteroides / Prevotella species and Clostridium
coccoides group loads could be detected in the ileal lumen
of Psae challenged as compared to naive mice (p < 0.05;
Figures 2F,G).
We additionally assessed the microbiota composition in the
large intestinal tract (Figures 3A–H). Within 9 days following
ileitis induction, total eubacterial loads increased in the colonic
lumen of both mock and Psae challenged mice (p < 0.01
and p < 0.005, respectively; Figure 3A). This also held true
for large intestinal enterobacteria (p < 0.005 and p < 0.001,
respectively; Figure 3B) and enterococci (p < 0.01; Figure 3C),
whereas Psae challenged animals displayed lower lactobacilli
loads in their colon as compared to mock treated controls at
day 9 p.i. (p < 0.05; Figure 3D). Hence, the intestinal loads of
assessed bacterial taxa, groups and species did not differ between
Psae challenged and unchallenged hma mice during subacute
ileitis.
Macroscopic and Microscopic
Inflammatory Sequelae of MDR P.
aeruginosa Challenge in Mice With a
Human Gut Microbiota Suffering From
Subacute Ileitis
We next assessed whether peroral Psae challenge worsened
subacute ileitis of hma mice. Mice of either treatment group
displayed mean body weight loss of ∼5% during the observation
period (not shown). At day 9 p.i., however, 58.8% of mock
treated mice exhibited blood in their feces, whereas this was
the case in 72.2% of Psae challenged and none of naive mice
(Figure 4A). Following ileitis induction, mice of either cohort
displayed comparable histopathological changes within the small
intestinal mucosa and lamina propria (p < 0.005 vs. naive
controls; Figure 4B). Of note, the range of histopathological
scores was higher following Psae as compared tomock challenged
mice at day 9 p.i., with single mice displaying even ileal necrosis
in the former cohort, which was not the case in the latter group
(Figure 4B).
FIGURE 3 | Colonic microbiota changes following MDR P. aeruginosa challenge of mice with a human gut microbiota suffering from subacute ileitis. Subacute ileitis
was induced in mice harboring a human gut microbiota by peroral T. gondii infection on day (d) 0. At day 5 post ileitis induction mice were either perorally challenged
with MDR P. aeruginosa (+Psae, dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as control
animals (Naive). (A–H) The microbiota composition of the colonic lumen was determined 96 h later by quantitative Real-Time PCR amplifying bacterial 16S rRNA
variable regions of the main intestinal bacterial groups (expressed as 16S rRNA gene numbers per ng DNA) including the total eubacterial load. Box plots represent
the 75th and 25th percentiles of the median (black bar inside the boxes). Total range and significance levels determined by one-way ANOVA test followed by Tukey
post-correction test for multiple comparisons are shown. Numbers of mice harboring respective bacterial groups in the colonic lumen out of the total numbers of
analyzed animals are given in parentheses. Data were pooled from four independent experiments.
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FIGURE 4 | Clinical and histopathological sequelae following peroral MDR P. aeruginosa challenge of mice with a human gut microbiota suffering from subacute ileitis.
At day 5 following subacute ileitis induction, mice with a human gut microbiota were either perorally challenged with MDR P. aeruginosa (+Psae, dissolved in PBS) or
with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as control animals (Naive). Clinical and microscopic intestinal changes
were assessed 96 h following Psae challenge. (A) Abundance of blood was determined in fecal samples by the Guajac (Haemoccult) method. Cumulative blood
positivity rates were calculated from four independent experiments. (B) Histopathological changes were determined in H&E stained ileal paraffin sections applying a
standardized scoring system (see methods) and representative photomicrographs depicted (right panel; 100x magnification, scale bar 100µm). Box plots represent
the 75th and 25th percentiles of the median (black bar inside the boxes). Total range and significance levels determined by one-way ANOVA test followed by Tukey
post-correction test for multiple comparisons are shown. The total numbers of analyzed animals are given in parentheses. Data were pooled from four independent
experiments.
Intestinal Apoptotic, Proliferating, and
Immune Cell Responses Upon MDR P.
aeruginosa Challenge of Mice With a
Human Gut Microbiota Suffering From
Subacute Ileitis
We further expanded our histopathological analyses and
quantitatively assessed apoptotic cells in the small intestinal
epithelia applying in situ imunohistochemistry. Ileitis
induction was accompanied by increased numbers of
caspase3+ ileal epithelial cells (p < 0.001; Figure 5A;
Supplemental Figure S3A). Of note, at day 9 p.i., Psae
challenged mice were suffering from even more distinct
ileal epithelial apoptosis as compared to mock treated mice
(p < 0.01; Figure 5A; Supplemental Figure S3A).
We further quantitated Ki67+ cells in ileal epithelia
indicative for proliferative/regenerative cell responses
counteracting potential Psae-induced cell damage. Until
day 9 p.i., Ki67+ cell numbers had markedly increased in the
ileal epithelia as compared to naive controls (p < 0.001;
Figure 5B; Supplemental Figure S3B), but irrespective
whether mice were Psae or mock challenged (n.s.; Figure 5B;
Supplemental Figure S3B).
Given that T. gondii induced ileitis comprises a T cell-
driven immunopathological scenario (29), we next assessed
T lymphocyte counts in ileal paraffin sections by in situ
imunohistochemistry. At day 9 p.i., T. gondii infected mice
displayed increased numbers of CD3+ cells in their ileal
mucosa and lamina propria, but exhibited even higher T
cell counts upon Psae as compared to mock challenge (p
< 0.001; Figure 5C; Supplemental Figure S3C). Interestingly,
increases in small intestinal T cell numbers following ileitis
induction were paralleled by elevated numbers of FOXP3+
cells in the ileal mucosa and lamina propria of both,
Psae and mock challenged mice at day 9 p.i. (p < 0.001;
Figure 5D; Supplemental Figure S3D) with higher counts in
the former as compared to the latter (p < 0.001; Figure 5D;
Supplemental Figure S3D).
Even though peroral T. gondii infection of susceptible
mice is well-known to affect primarily the terminal ileum
(29), we additionally included the large intestines into
our immunohistopathological survey. Interestingly, ileitis
induction was also accompanied by increases in apoptotic
cell numbers in colonic epithelia (p < 0.001; Figure 5E;
Supplemental Figure S3E) with a trend toward even higher
counts in Psae as compared to mock treated mice at day 9 p.i.
(n.s. due to high standard deviations). Like in the ileum, T. gondii
infection resulted in increased Ki67+ colonic epithelial numbers
(p< 0.001; Figure 5F; Supplemental Figure S3F), that were even
more pronounced in Psae as compared to mock challenged mice
(p < 0.01; Figure 5F; Supplemental Figure S3F). Furthermore,
T. gondii induced elevated numbers of both CD3+ and
FOXP3+ cells could be determined in the mucosa and
lamina propria of the large intestines at day 9 p.i. (p < 0.001;
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FIGURE 5 | Apoptotic and proliferating epithelial cell as well as immune cell responses in the ileum and colon following peroral MDR P. aeruginosa challenge of mice
with a human gut microbiota suffering from subacute ileitis. At day 5 following subacute ileitis induction, mice with a human gut microbiota were either perorally
challenged with MDR P. aeruginosa (+Psae, dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as
control animals (Naive). 96 h following Psae challenge, the average numbers of apoptotic (Casp3+; A,E) and proliferating (Ki67+; B,F) epithelial cells as well as of T
lymphocytes (CD3+; C,G), and regulatory T cells (FOXP3+; D,H) in at least six high power fields (HPF) were quantitatively assessed in ileal (A–D) and colonic (E–H)
paraffin sections applying in situ immunhistochemistry. Box plots represent the 75th and 25th percentiles of the median (black bar inside the boxes). The total range
and significance levels determined by one-way ANOVA test followed by Tukey post-correction test for multiple comparisons are shown. The total numbers of analyzed
animals are given in parentheses. Data were pooled from four independent experiments.
Figures 5G,H; Supplemental Figures S3G,H) with even higher
counts in the Psae vs. mock cohort (p < 0.001; Figures 5G,H;
Supplemental Figures S3G,H). Hence, Psae challenge resulted
in more pronounced intestinal epithelial apoptotic and T cell
responses upon ileitis induction that were not restricted to the
ileum, but also involved the large intestines.
Intestinal Pro-Inflammatory Mediator
Responses Upon MDR P. aeruginosa
Challenge of Mice With a Human Gut
Microbiota Suffering From Subacute Ileitis
We next addressed whether changes in apoptotic and immune
cell responses upon Psae challenge of hma mice with subacute
ileitis was accompanied by pro-inflammatory mediator responses
in the intestinal tract. Irrespective whether Psae or mock
challenged, hma mice displayed increased IFN-γ concentrations
in ex vivo biopsies derived from the ileum, colon or MLN at day 9
p.i. (p< 0.001 vs. naive controls; Supplemental Figures S4A–C).
In addition, TNF and NO were multi-fold elevated in MLN
following ileitis induction in either cohort (p < 0.005–0.001
vs. naive; Supplemental Figures S4D,E). Hence, Psae challenge
did not result in further augmented pro-inflammatory mediator
responses in the intestinal tract following subacute ileitis
induction of hma mice.
Extra-Intestinal Apoptotic, Proliferating,
and Immune Cell Responses Upon MDR
P. aeruginosa Challenge of Mice With a
Human Gut Microbiota Suffering From
Subacute Ileitis
We next addressed whether peroral MDR Psae challenge of
hma mice with subacute ileitis might lead to more pronounced
inflammatory responses in extra-intestinal compartments
including liver, kidney, lung, and heart. Nine days following
ileitis induction, hma mice exhibited increased numbers
of apoptotic hepatic cells (p < 0.001 vs. naive; Figure 6A;
Supplemental Figure S5A) that were even higher upon Psae
as compared to mock challenge (p < 0.001; Figure 6A;
Supplemental Figure S5A). Increases in apoptotic cells were
paralleled by elevated T lymphocyte and Treg counts in
the livers of both, Psae and mock challenged mice at day 9
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FIGURE 6 | Apoptotic epithelial cell as well as immune cell responses in the liver and kidney following peroral MDR P. aeruginosa challenge of mice with a human gut
microbiota suffering from subacute ileitis. At day 5 following subacute ileitis induction, mice with a human gut microbiota were either perorally challenged with MDR P.
aeruginosa (+Psae, dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as control animals (Naive).
96 h following Psae challenge, the average numbers of apoptotic (Casp3+; A,D) epithelial cells as well as of T lymphocytes (CD3+; B,E) and regulatory T cells
(FOXP3+; C,F) in at least six high power fields (HPF) were quantitatively assessed in hepatic (A–C) and renal (D–F) paraffin sections applying in situ
immunhistochemistry. Box plots represent the 75th and 25th percentiles of the median (black bar inside the boxes). The total range and significance levels determined
by one-way ANOVA test followed by Tukey post-correction test for multiple comparisons are shown. The total numbers of analyzed animals are given in parentheses.
Data were pooled from four independent experiments.
p.i. (p < 0.001; Figures 6B,C; Supplemental Figures S5B,C
with higher numbers in the former as compared to the
latter (p < 0.001 and p < 0.05, respectively; Figures 6B,C;
Supplemental Figures S5B,C.
In the kidney, apoptotic cells, CD3+ and FOXP3+ cells
increased upon ileitis induction of hma mice until day 9
p.i. (Figures 6D–F, Supplemental Figures S5D–F). Additional
Psae challenge resulted in more pronounced increases in renal
T lymphocytes as compared to the mock cohort (Figure 6E;
Supplemental Figure S5E), whereas a trend toward higher
Casp3+ and FOXP3+ cell counts could be observed in the
kidneys following Psae challenge at day 9 p.i. (n.s.; Figures 6D,F,
Supplemental Figures S5D,F).
Also in lung and heart, elevated apoptotic cell numbers could
be observed 9 days following ileitis induction in either cohort
(p < 0.005 and p < 0.05 vs. naive, respectively; Figures 7A,D,
Supplemental Figures S6A,D) that were accompanied by
multi-fold increased T lymphocyte counts in both organs
(p < 0.001; Figures 7B,E, Supplemental Figures S6B,E).
Remarkably, increases in T cell numbers in lung and heart were
more pronounced in Psae as compared to mock challenged
mice (p < 0.01 and p < 0.05, respectively; Figures 7B,E,
Supplemental Figures S6B,E). Only in the lung, but not in
the heart, higher Treg numbers could be assessed at day 9 p.i.
(p < 0.001; Figures 7C,F, Supplemental Figures S6C,F) with
similar counts in either cohort. Hence, additional peroral Psae
challenge resulted in increased apoptotic and T cell responses in
extra-intestinal compartments.
Extra-Intestinal Inflammatory Mediator
Responses Upon MDR P. aeruginosa
Challenge of Mice With a Human Gut
Microbiota Suffering From Subacute Ileitis
We further assessed whether the observed increased apoptotic
and immune cell responses in extra-intestinal compartments
upon Psae challenge of hma mice with subacute ileitis were
accompanied by pronounced inflammatory mediator secretion.
Nine days following ileitis induction increased concentrations
of pro-inflammatory cytokines such as IFN-γ and TNF could
be observed in the liver of hma mice (p < 0.005–0.001;
Figures 8A,B), but with no differences between mice of
either cohort. Interestingly, hepatic concentrations of the anti-
inflammatory cytokine IL-10 were elevated in mock treated, but
not Psae challenged mice at day 9 p.i. (p < 0.005 vs. naive, p <
0.05 vs. Psae; Figure 8C).
In the kidney, pro-inflammatory cytokines including IFN-γ,
TNF, MCP-1, and IL-6 were increased to similar extent in Psae
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FIGURE 7 | Apoptotic epithelial cell as well as immune cell responses in the lung and heart following peroral MDR P. aeruginosa challenge of mice with a human gut
microbiota suffering from subacute ileitis. At day 5 following subacute ileitis induction, mice with a human gut microbiota were either perorally challenged with MDR P.
aeruginosa (+Psae, dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as control animals (Naive).
96 h following Psae challenge, the average numbers of apoptotic (Casp3+; A,D) epithelial cells as well as of T lymphocytes (CD3+; B,E) and regulatory T cells
(FOXP3+; C,F) in at least six high power fields (HPF) were quantitatively assessed in pulmonal (A–C) and cardiac (D–F) paraffin sections applying in situ
immunhistochemistry. Box plots represent the 75th and 25th percentiles of the median (black bar inside the boxes). The total range and significance levels determined
by one-way ANOVA test followed by Tukey post-correction test for multiple comparisons are shown. The total numbers of analyzed animals are given in parentheses.
Data were pooled from four independent experiments.
andmock challengedmice at day 9 p.i. (p< 0.005–0.001 vs. naive;
Supplemental Figure S7), which also held true for pulmonal
IFN-γ, TNF, MCP-1, and IL-10 concentrations (p < 0.005–0.001
vs. naive; Supplemental Figure S8).
Hence, Psae challenge during subacute ileitis of hma mice
did not result in further increased pro-inflammatory cytokine
secretion in extra-intestinal organs, but led to a dampened anti-
inflammatory IL-10 response in the liver.
Systemic Pro-Inflammatory Mediator
Responses Upon MDR P. aeruginosa
Challenge of Mice With a Human Gut
Microbiota Suffering From Subacute Ileitis
In the following we measured systemic cytokine secretion upon
Psae challenge of hma mice during subacute ileitis. At day
9 p.i., increased pro-inflammatory mediators such as IFN-γ,
TNF, and NO could be assessed in the spleen derived from
mice of either cohort (p < 0.001; Supplemental Figure S9). In
corresponding serum samples, increased IFN-γ, TNF, IL-6,MCP-
1, and IL-10 concentrations were determined at day 9 p.i. (p
< 0.05–0.001; Figure 9). Strikingly, even higher TNF and IL-
6 levels could be measured in serum samples taken from Psae
as compared to mock challenged hma mice with ileitis (p <
0.01; Figures 9 B,C). Of note, no viable bacteria that might
have translocated from the intestinal tract to extra-intestinal and
systemic tissue sites during subacute ileitis could be isolated from
liver, kidney, lung, heart, spleen, or cardiac blood (not shown).
Hence, Psae challenge of hma mice with induced subacute ileitis
resulted in an augmented systemic pro-inflammatory cytokine
response.
DISCUSSION
In recent years the global emergence of MDR Gram-negative
species including Psae in humans as well as in livestock animals
has come more and more into the focus of awareness (11, 30).
In fact, the increasing prevalence of severe infections caused by
MDR Gram-negative bacteria which allow for only very limited
options to combat disease contributing to high fatality rates, has
not only gained access to the conscience of medical professionals,
but also to (health care) politicians as well as to the general public.
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FIGURE 8 | Pro- and anti-inflammatory mediator responses in the liver following peroral MDR P. aeruginosa challenge of mice with a human gut microbiota suffering
from subacute ileitis. At day 5 following subacute ileitis induction, mice with a human gut microbiota were either perorally challenged with MDR P. aeruginosa (+Psae,
dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as control animals (Naive). 96 h following Psae
challenge, (A) IFN-γ, (B) TNF, and (C) IL-10 concentrations were determined in hepatic ex vivo biopsies. Box plots represent the 75th and 25th percentiles of the
median (black bar inside the boxes). The total range and significance levels determined by one-way ANOVA test followed by Tukey post-correction test for multiple
comparisons are shown. The total number of analyzed animals are given in parentheses. Data were pooled from four independent experiments.
In consequence and of utmost importance, theWHO ratedMDR
Gram-negative species such as Psae as serious global threat to
human health recently (4).
In healthcare settings, the risk of a patient for MDR Psae
acquisition increases with the length of the hospital stay, most
likely due to spread of the opportunistic pathogen from external
sources such as contaminated surfaces and medical devices
and/or via smear infection from body fluids or fecal samples
derived from colonized/infected patients (5, 6, 31). Particularly
information regarding prevalence of human intestinal Psae
carriage are scarce, however, and range from 0 to 24%
in healthy individuals (31–40), hence speaking against Psae
as part of the commensal gut microbiota. One of the key
factors facilitating stable intestinal (opportunistic) pathogenic
colonization including Psae in mice and men, however, is
antibiotic pre-treatment compromising the integrity of the
complex gut microbiota, which subsequently provides open
niches for the acquired bacteria and hence, potential internal
sources for MDR Psae-associated infections lateron (8, 9, 41,
42). In fact, fecal Psae carriage before ICU admission has
been shown to be associated with an ∼15-times increased risk
for subsequent Psae-induced nosocomial infection (7), which
might even more likely mount in a fatal outcome, given that
particularly antibiotics-treated ICU patients with concomitant
severe comorbidities including immunosuppression are prone to
MDR Psae infection arising from the indigenous gut microbiota
(3, 11, 43). It is therefore crucial to identify distinct risk factors
including immunopathological conditions that might facilitate
MDR Psae acquisition by the vertebrate host. Recent studies
report higher abundances of Psae in the GIT of patients with
underlying intestinal inflammatory diseases such as irritable
bowel diseases or ulcerative colitis (40, 44). Interestingly, in
our recent study MDR Psae could not only stably colonize
the gut, but also induce overt inflammatory immune responses
in intestinal, extra-intestinal and even systemic compartments
upon peroral challenge of healthy WT mice that were lacking
a gut microbiota due to preceding broad-spectrum antibiotic
treatment (13). This was also the case, when (with respect to the
gut microbiota) “humanized” and clinically uncompromisedWT
mice were subjected to the identical clinical MDR Psae strain
(14).
In the present study, we had challenged hma mice with
the opportunistic pathogen after subacute ileitis induction
following peroral low-dose T. gondii infection—a non-lethal
small intestinal inflammation model that has been established by
us recently (19). Four days upon peroral application of a rather
“supra-physiological” dose of 109 CFU, Psae could be isolated
from the intestinal tract in approximately one third of hma mice
with subacute ileitis and if so, in relatively low counts of <105
CFU per g luminal sample. In our previous study, intestinal MDR
Psae could be cultured in up to 78% of healthy hma mice (i.e.,
without underlying intestinal inflammatory conditions) 4 weeks
following peroral challenge with comparable loads (14). In line
with results obtained from our mouse studies, fecal Psae counts
were up to 5 log orders of magnitude lower in healthy human
volunteers as compared to the bacterial counts within the oral
suspension 6 days before (12).
Remarkably, irrespective of the (opportunistic) pathogenic
bacterial carrier status, Psae-challenged mice appeared to display
more pronounced clinical/macroscopic and microscopic features
of subacute ileitis. Whereas, 72.2% of mice from the Psae cohort
displayed macroscopic and/or microscopic abundance of blood
in their feces 4 day after Psae challenge, this was only the case
in 58.8% of mock counterparts. In support, the histopathological
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FIGURE 9 | Systemic pro- and anti-inflammatory mediator responses following peroral MDR P. aeruginosa challenge of mice with a human gut microbiota suffering
from subacute ileitis. At day 5 following subacute ileitis induction, mice with a human gut microbiota were either perorally challenged with MDR P. aeruginosa (+Psae,
dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut microbiota but without ileitis served as control animals (Naive). 96 h following Psae
challenge, (A) IFN-γ, (B) TNF, (C) IL-6, (D) MCP-1, and (E) IL-10 concentrations were determined in serum samples. Box plots represent the 75th and 25th
percentiles of the median (black bar inside the boxes). The total range and significance levels determined by one-way ANOVA test followed by Tukey post-correction
test for multiple comparisons are shown. The total number of analyzed animals are given in parentheses. Data were pooled from four independent experiments.
changes in the ileal mucosa tended to be more severe in the Psae
cohort as compared to the mock controls, given that individual
mice exhibited even virtually fatal ileal mucosal changes such
as transmural necrosis 4 days post Psae challenge, which could
not be observed in the mock counterparts. The relatively high
standard deviation in histopathological scores within the MDR
Psae cohort points toward (yet unknown) distinct host factors
that might determine the individual outcome of subacute ileitis
upon Psae infection.
Furthermore, Psae induced a marked influx of T lymphocytes
into the mucosa and lamina propria of both, the ileum and the
colon that was accompanied by pronounced apoptotic responses
in the ileal epithelia. Remarkably, the marked Psae-induced
T cell responses were not restricted to the intestinal tract,
but could also be observed in extra-intestinal compartments
such as liver, kidney, lungs, and even the heart. In the liver,
significant Psae-induced apoptotic changes could be further
assessed and were accompanied by less distinct secretion of the
anti-inflammatory cytokine IL-10 as compared to mock control
mice. Strikingly, Psae challenged hma mice with subacute ileitis
displayed even more pronounced systemic pro-inflammatory
cytokine responses versus mock counterparts as indicated by
higher TNF and IL-6 serum concentrations in the former as
compared to the latter. In this context we were, however, not able
to detect any viable bacteria originating from the gut microbiota
including Psae that had translocated to extra-intestinal including
systemic compartments. Nevertheless, it cannot be excluded that
soluble bacterial factors including lipopolysaccharide derived
from Gram-negative intestinal commensals or from MDR Psae
might have found access to the circulation evoking systemic
pro-inflammatory immune responses.
In support of our actual results, we demonstrated previously
that peroral MDR Psae application to conventionally colonized
IL-10−/− mice suffering from chronic colitis aggravated the
outcome of the underlying intestinal immunopathological
disease (16), again not only on the local (i.e., intestinal) level,
but also beyond (i.e., in extra-intestinal and even systemic
compartments).
Another recent study applying a lethal acute ileitis model
induced by peroral high-dose (i.e., >50 cysts) T. gondii
infection of hma mice revealed that the underlying acute gut
inflammation facilitated Psae colonization (15). The severity
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of the gut inflammation model was, however, far too acute
to decipher additional Psae induced inflammatory sequelae
further accelerating the underlying (already hyper-acute)
immunopathology (15).
Nevertheless, given the multitude of so far known Psae
virulence factor it is not surprising that intestinal Psae carriage
in health and disease mounts in immune responses accelerating
the underlying disease. The Pseudomonas lipid A moiety,
for instance, is part of the Gram-negative bacterial cell wall
constituent lipopeptide and able to activate NFκB in a Toll-like
receptor (TLR)−4 dependent fashion (45), which subsequently
leads to recruitment of innate immune cells to the infection
site, further perpetuating host immune responses in order to
combat the (opportunistic) pathogenic challenge (1). In support,
our previous studies revealed that, in fact, TLR-4 was involved
in differentially mediating MDR Psae associated intestinal and
extra-intestinal immune responses in IL-10−/− mice (46, 47).
The observed Psae induced immunopathological sequelae in
hma mice with subacute ileitis -irrespective of the intestinal
carrier status—are supported by our results derived from
Campylobacter jejuni infection experiments indicating that a
pathogen does not necessarily needs to be a permanent member
of the intestinal ecosystem to induce pro-inflammatory responses
(26, 48–50). More importantly, it is rather the initial hit set
by the (opportunistic) pathogen that tips the balance toward
immunopathology within the “ménage à trois” of (opportunistic)
pathogens, commensal gut microbiota and host immunity (47,
48).
We further assessed whether Psae application resulted in
changes of the gut microbiota composition applying culture-
independent methods, but could neither find any significant
and biologically relevant Psae-induced changes in the luminal
microbiota of the inflamed ileum, nor in the co-affected colon.
One might, in fact, argue that the observation period of 4
days was far too short for overt changes in the intestinal
ecosystem. Nevertheless, our actual results are supported by our
previous study where even an intestinal carriage of MDR Psae
by conventional IL-10−/− mice with chronic colitis for 6 weeks
was not associated with significant changes in the gut microbiota
composition as assessed by both, culture and molecular analyses
(16).
In conclusion, our actual and previous studies revealed
that peroral exposure to MDR Gram-negative opportunistic
pathogenic species including Psae might worsen the outcome of
underlying inflammatory conditions within the gut. In ongoing
studies we are currently exploring antibiotics-independent
factors preventing the susceptible host at risk including
individuals suffering from inflammatory intestinal comorbidities
from Psae-carriage and induced inflammation.
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Supplemental Figure S1 | Experimental setup. The gut microbiota was depleted
in conventional mice by broad-spectrum antibiotic treatment for 8 weeks. Three
days before human fecal microbiota transplantation (FMT) the antibiotic cocktail
was replaced by sterile tap water to assure antibiotic washout. Microbiota
depleted animals were then subjected to human FMT on three consecutive days.
In order to guarantee proper establishment of the complex human gut microbiota
within the murine host, mice were kept for 10 days before subacute ileitis
induction. At day 0, human microbiota associated (hma) mice were perorally
subjected to low dose (i.e., one cyst) infection with T. gondii infection. 5 days later
(d+5), hma mice with induced subacute ileitis were perorally challenged with a
multi-drug resistant (MDR) P. aeruginosa (Psae) strain and followed up for another
4 days (d+9; necropsy).
Supplemental Figure S2 | Microbiota composition of human donor feces. Before
human fecal microbiota transplantation of secondary abiotic mice on three
consecutive days, main intestinal bacterial groups were quantitatively assessed in
human fecal donor suspensions. 16S rRNA of the main intestinal bacterial
commensals including enterobacteria (EB), enterococci (EC), lactobacilli (LB),
bifidobacteria (Bif), Bacteroides / Prevotella species (B/P), Clostridium coccoides
group (Clocc), Clostridium leptum group (Clept), and the total eubacterial load (TL)
were analyzed by quantitative RT-PCR and expressed as gene numbers per ng
DNA. Data shown are representative for four independent experiments. Total
range as well as box plots representing the 75th and 25th percentiles of the
median (black bar inside the boxes) are shown.
Supplemental Figure S3 | Representative photomicrographs depicting apoptotic
and proliferating epithelial cell as well as immune cell responses in the ileum and
colon following peroral MDR P. aeruginosa challenge of mice with a human gut
microbiota suffering from subacute ileitis. At day 5 following subacute ileitis
induction, mice with a human gut microbiota were either perorally challenged with
MDR P. aeruginosa (ILE, Psae; dissolved in PBS) or with PBS alone (ILE, Mock).
Uninfected mice with a human gut microbiota but without ileitis served as control
animals (Naive). Representative photomicrographs out of four independent
experiments illustrate the average numbers of apoptotic (Casp3+; A,E) and
proliferating (Ki67+; B,F) epithelial cells as well as of T lymphocytes (CD3+; C,G)
and regulatory T cells (FOXP3+; D,H) in at least six high power fields (HPF) that
had been quantitatively assessed in ileal (A–D) and colonic (E–H) paraffin sections
96 h following Psae challenge applying in situ immunhistochemistry (100x
magnification; scale bar: 100µm).
Supplemental Figure S4 | Intestinal pro-inflammatory mediator responses
following peroral MDR P. aeruginosa challenge of mice with a human gut
microbiota suffering from subacute ileitis. At day 5 following subacute ileitis
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induction, mice with a human gut microbiota were either perorally challenged with
MDR P. aeruginosa (+Psae, dissolved in PBS) or with PBS alone (Mock).
Uninfected mice with a human gut microbiota but without ileitis served as control
animals (Naive). 96 h following Psae challenge, IFN-γ concentrations were
measured in ex vivo biopsies derived from the (A) ileum, (B) colon, and (C)
mesenteric lymph nodes (MLN). In addition, (D) TNF and (E) nitric oxide levels
were determined in MLN ex vivo biopsies. Box plots represent the 75th and 25th
percentiles of the median (black bar inside the boxes). The total range and
significance levels determined by one-way ANOVA test followed by Tukey
post-correction test for multiple comparisons are shown. The total numbers of
analyzed animals are given in parentheses. Data were pooled from four
independent experiments.
Supplemental Figure S5 | Representative photomicrographs depicting apoptotic
epithelial cell as well as immune cell responses in the liver and kidney following
peroral MDR P. aeruginosa challenge of mice with a human gut microbiota
suffering from subacute ileitis. At day 5 following subacute ileitis induction, mice
with a human gut microbiota were either perorally challenged with MDR P.
aeruginosa (ILE, Psae; dissolved in PBS) or with PBS alone (ILE, Mock). Uninfected
mice with a human gut microbiota but without ileitis served as control animals
(Naive). Representative photomicrographs out of four independent experiments
illustrate the average numbers of apoptotic (Casp3+; A,D) epithelial cells as well
as of T lymphocytes (CD3+; B,E) and regulatory T cells (FOXP3+; C,F) in at least
six high power fields (HPF) that had been were quantitatively assessed in hepatic
(A–C) and renal (D–F) paraffin sections 96 h following Psae challenge applying in
situ immunhistochemistry (100x magnification; scale bar: 100µm).
Supplemental Figure S6 | Representative photomicrographs depicting apoptotic
epithelial cell as well as immune cell responses in the lung and heart following
peroral MDR P. aeruginosa challenge of mice with a human gut microbiota
suffering from subacute ileitis. At day 5 following subacute ileitis induction, mice
with a human gut microbiota were either perorally challenged with MDR P.
aeruginosa (ILE, Psae; dissolved in PBS) or with PBS alone (ILE, Mock). Uninfected
mice with a human gut microbiota but without ileitis served as control animals
(Naive). Representative photomicrographs out of four independent experiments
illustrate the average numbers of apoptotic (Casp3+; A,D) epithelial cells as well
as of T lymphocytes (CD3+; B,E) and regulatory T cells (FOXP3+; C,F) in at least
six high power fields (HPF) that had been were quantitatively assessed in pulmonal
(A–C) and cardiac (D–F) paraffin sections 96 h following Psae challenge applying
in situ immunhistochemistry (100x magnification; scale bar: 100µm).
Supplemental Figure S7 | Cytokine responses in the kidneys following peroral
MDR P. aeruginosa challenge of mice with a human gut microbiota suffering from
subacute ileitis. At day 5 following subacute ileitis induction, mice with a human
gut microbiota were either perorally challenged with MDR P. aeruginosa (+Psae,
dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut
microbiota but without ileitis served as control animals (Naive). 96 h following Psae
challenge, (A) IFN-γ, (B) TNF, (C) MCP-1, and (D) IL-6 concentrations were
determined in renal ex vivo biopsies. Box plots represent the 75th and 25th
percentiles of the median (black bar inside the boxes). The total range and
significance levels determined by one-way ANOVA test followed by Tukey
post-correction test for multiple comparisons are shown. The total numbers of
analyzed animals are given in parentheses. Data were pooled from four
independent experiments.
Supplemental Figure S8 | Cytokine responses in the lungs following peroral
MDR P. aeruginosa challenge of mice with a human gut microbiota suffering from
subacute ileitis. At day 5 following subacute ileitis induction, mice with a human
gut microbiota were either perorally challenged with MDR P. aeruginosa (+Psae,
dissolved in PBS) or with PBS alone (Mock). Uninfected mice with a human gut
microbiota but without ileitis served as control animals (Naive). 96 h following Psae
challenge, (A) IFN-γ, (B) TNF, (C) MCP-1, and (D) IL-10 concentrations were
determined in pulmonal ex vivo biopsies. Box plots represent the 75th and 25th
percentiles of the median (black bar inside the boxes). The total range and
significance levels determined by one-way ANOVA test followed by Tukey
post-correction test for multiple comparisons are shown. The total numbers of
analyzed animals are given in parentheses. Data were pooled from four
independent experiments.
Supplemental Figure S9 | Pro-inflammatory mediator responses in the spleen
following peroral MDR P. aeruginosa challenge of mice with a human gut
microbiota suffering from subacute ileitis. At day 5 following subacute ileitis
induction, mice with a human gut microbiota were either perorally challenged with
MDR P. aeruginosa (+Psae, dissolved in PBS) or with PBS alone (Mock).
Uninfected mice with a human gut microbiota but without ileitis served as control
animals (Naive). 96 h following Psae challenge, (A) IFN-γ, (B) TNF, and (C) nitric
oxide concentrations were determined in splenic ex vivo biopsies. Box plots
represent the 75th and 25th percentiles of the median (black bar inside the
boxes). The total range and significance levels determined by one-way ANOVA
test followed by Tukey post-correction test for multiple comparisons are shown.
The total numbers of analyzed animals are given in parentheses. Data were
pooled from four independent experiments.
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